|
5971 |
PD-1-Hemmer verbessert Erstlinientherapie beim Ösophaguskarzinom Enthalten in Im Focus Onkologie Bd. 25, 2.2.2022, Nr. 1, date:2.2022: 38
|
|
|
5972 |
PD-1-Hemmer verlängert Leben bei Nasopharynxkarzinom Enthalten in Im Focus Onkologie Bd. 27, 2.2.2024, Nr. 1, date:2.2024: 55
|
|
|
5973 |
Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy —short version of the updated German best practice guideline (S2e) — AWMF register no. 166-001, 6/2020 Enthalten in Pediatric nephrology Bd. 36, 6.6.2021, Nr. 10, date:10.2021: 2971-2985
|
|
|
5974 |
Penisnekrose nach Prostata-Embolisation Enthalten in Uro-News Bd. 28, 9.10.2024, Nr. 10, date:10.2024: 8
|
|
|
5975 |
Performance of microAethalometers: Real-world Field Intercomparisons from Multiple Mobile Measurement Campaigns in Different Atmospheric Environments Enthalten in Aerosol and Air Quality Research Bd. 20, 10.9.2020, Nr. 12, date:12.2020: 2640-2653
|
|
|
5976 |
Perioperative and Long-Term Outcomes in Patients Undergoing Synchronous Carotid Endarterectomy and Coronary Artery Bypass Grafting: A Single-Center Experience Enthalten in Advances in therapy Bd. 41, 13.3.2024, Nr. 5, date:5.2024: 1911-1922
|
|
|
5977 |
Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective Enthalten in Langenbeck's archives of surgery Bd. 408, 10.2.2023, Nr. 1, date:12.2023: 1-15
|
|
|
5978 |
Persistierende Riechminderung nach COVID-19 – Empfehlungen der Arbeitsgemeinschaft Olfaktologie und Gustologie der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V Enthalten in HNO Bd. 71, 6.10.2023, Nr. 11, date:11.2023: 739-743
|
|
|
5979 |
Pflegende Angehörige während der Pandemie Enthalten in Die Neurologie & Psychiatrie Bd. 23, 4.10.2022, Nr. 5, date:10.2022: 16-17
|
|
|
5980 |
Phantosmie: Frauen sind häufiger betroffen Enthalten in HNO-Nachrichten Bd. 48, 29.9.2018, Nr. 5, date:10.2018: 8
|
|